Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 10/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.48 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11001290 | 0.89 | SLC6A3 (0.59) | SLC6A3SLC6A2SLC6A4LMNAALDH1A1 | |
| SCHEMBL14739505 | 0.82 | SLC6A3 (0.50) | SLC6A3SLC6A2SLC6A4LMNAALDH1A1 | |
| SCHEMBL14739506 | 0.79 | SLC6A3 (0.50) | SLC6A3SLC6A2SLC6A4LMNAALDH1A1 | |
| SCHEMBL5487986 | 0.77 | SLC6A3 (0.57) | SLC6A3SLC6A2SLC6A4LMNAALDH1A1 | |
| SCHEMBL1626214 | 0.77 | SLC6A3 (0.57) | SLC6A3SLC6A2SLC6A4LMNAALDH1A1 | |
| SCHEMBL1566492 | 0.77 | SLC6A3 (0.57) | SLC6A3SLC6A2SLC6A4LMNAALDH1A1 | |
| SCHEMBL1566494 | 0.77 | SLC6A3 (0.57) | SLC6A3SLC6A2SLC6A4LMNAALDH1A1 | |
| SCHEMBL9395161 | 0.76 | SLC6A3 (0.56) | SLC6A3SLC6A2SLC6A4LMNAALDH1A1 | |
| SCHEMBL6988620 | 0.76 | SLC6A3 (0.56) | SLC6A3SLC6A2SLC6A4LMNAALDH1A1 | |
| SCHEMBL30522901 | 0.76 | SLC6A3 (0.56) | SLC6A3SLC6A2SLC6A4LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2246343-B1 | PROCESS FOR PRODUCTION OF THIOPHENE COMPOUND AND INTERMEDIATE THEREOF | NISSAN CHEMICAL IND LTD (JP) | 2016-05-18 | — | — | EP | disclosed |
| US-8642786-B2 | Process for producing thiophene compound and intermediate thereof | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2014-02-04 | — | — | US | disclosed |
| US-20140005413-A2 | PROCESS FOR PRODUCING THIOPHENE COMPOUND AND INTERMEDIATE THEREOF | NISSAN CHEMICAL IND LTD (JP) | 2014-01-02 | — | — | US | disclosed |
| US-20130204013-A1 | PROCESS FOR PRODUCING THIOPHENE COMPOUND AND INTERMEDIATE THEREOF | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2013-08-08 | — | — | US | disclosed |
| US-8420849-B2 | Process for producing thiophene compound and intermediate thereof | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2013-04-16 | — | — | US | disclosed |
| US-8399685-B2 | Process for producing thiophene compound and intermediate thereof | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2013-03-19 | — | — | US | disclosed |
| US-20130060050-A1 | PROCESS FOR PRODUCING THIOPHENE COMPOUND AND INTERMEDIATE THEREOF | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2013-03-07 | — | — | US | disclosed |
| US-20110124884-A1 | PROCESS FOR PRODUCING THIOPHENE COMPOUND AND INTERMEDIATE THEREOF | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2011-05-26 | — | — | US | disclosed |
| EP-2246343-A1 | PROCESS FOR PRODUCTION OF THIOPHENE COMPOUND AND INTERMEDIATE THEREOF | Nissan Chemical Industries, Ltd. (JP) | 2010-11-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130060050-A1 | PROCESS FOR PRODUCING THIOPHENE COMPOUND AND INTERMEDIATE THEREOF | SULT1E1, CYP3A4, TKT | SLC6A3 4010/4885SLC6A2 4760/4885SLC6A4 3166/4885 |
| US-20130204013-A1 | PROCESS FOR PRODUCING THIOPHENE COMPOUND AND INTERMEDIATE THEREOF | TST, SULT1E1, GRHPR | SLC6A3 3041/4885SLC6A2 4474/4885SLC6A4 3021/4885 |
| US-20140005413-A2 | PROCESS FOR PRODUCING THIOPHENE COMPOUND AND INTERMEDIATE THEREOF | TST, SULT1E1, GRHPR | SLC6A3 3041/4885SLC6A2 4474/4885SLC6A4 3021/4885 |
| US-20110124884-A1 | PROCESS FOR PRODUCING THIOPHENE COMPOUND AND INTERMEDIATE THEREOF | TST, SULT1E1, GRHPR | SLC6A3 3041/4885SLC6A2 4474/4885SLC6A4 3021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.